EKF Diagnostics Holdings PLC Result of AGM and Voting Results
14 Mayo 2024 - 7:15AM
RNS Regulatory News
RNS Number : 3987O
EKF Diagnostics Holdings PLC
14 May 2024
EKF Diagnostics Holdings
plc
("EKF" or
the "Company")
Result of AGM and Voting
Results
EKF Diagnostics Holdings
plc (AIM: EKF), the AIM-listed global diagnostics business,
announces that at its Annual General
Meeting ("AGM") held earlier today, all resolutions were duly
passed.
The voting results of the AGM were
as follows:
|
|
For
|
Against
|
Withheld
|
|
Resolution
|
Votes
|
%
|
Votes
|
%
|
Votes
|
|
1
|
248,228,094
|
99.78%
|
547,604
|
0.22%
|
58,727,253
|
|
2
|
306,929,202
|
99.99%
|
17,611
|
0.01%
|
556,138
|
|
3
|
307,478,974
|
100.00%
|
13,855
|
0.00%
|
10,122
|
|
4
|
242,675,522
|
97.55%
|
6,098,796
|
2.45%
|
58,728,633
|
|
5
|
307,473,521
|
99.99%
|
19,308
|
0.01%
|
10,122
|
|
6
|
307,471,021
|
99.99%
|
21,808
|
0.01%
|
10,122
|
|
7
|
302,901,784
|
98.51%
|
4,594,167
|
1.49%
|
7,000
|
|
8
|
307,478,340
|
99.99%
|
16,355
|
0.01%
|
8,256
|
|
9
|
307,474,469
|
99.99%
|
16,029
|
0.01%
|
12,453
|
|
10*
|
305,495,468
|
99.35%
|
1,998,483
|
0.65%
|
9,000
|
|
11*
|
251,801,517
|
81.89%
|
55,692,434
|
18.11%
|
9,000
|
|
12*
|
247,115,598
|
83.20%
|
49,902,353
|
16.80%
|
10,485,000
|
*Special Resolutions
|
EKF
Diagnostics Holdings plc
|
www.ekfdiagnostics.com
|
|
Julian Baines, Executive Chair /
Stephen Young, CFO
|
via Walbrook
PR
|
|
|
|
|
Singer Capital Markets (Nominated
Adviser & Broker)
|
Tel: +44
(0)20 7496 3000
|
|
Aubrey Powell / Oliver
Platts
|
|
|
|
|
|
Walbrook PR Limited
|
Tel: +44 (0)20 7933 8780
or ekf@walbrookpr.com
|
|
Paul McManus / Alice
Woodings
|
Mob: +44
(0)7980 541 893 / +44 (0)7407 804 654
|
|
|
|
| |
About EKF Diagnostics Holdings plc (www.ekfdiagnostics.com)
EKF is an AIM-listed global
diagnostics business focussed on:
|
●
|
Point-of-Care analysers in the
key areas of Hematology and Diabetes
|
|
●
|
Life Sciences services provide
specialist manufacture of enzymes and custom products for use in
diagnostic, food and industrial applications.
|
EKF has headquarters in Penarth
(near Cardiff) and operates five manufacturing sites across the US
and Germany, selling into over 120 countries world-wide.
This information is provided by RNS, the news service of the
London Stock Exchange. RNS is approved by the Financial Conduct
Authority to act as a Primary Information Provider in the United
Kingdom. Terms and conditions relating to the use and distribution
of this information may apply. For further information, please
contact
rns@lseg.com or visit
www.rns.com.
RNS may use your IP address to confirm compliance with the terms
and conditions, to analyse how you engage with the information
contained in this communication, and to share such analysis on an
anonymised basis with others as part of our commercial services.
For further information about how RNS and the London Stock Exchange
use the personal data you provide us, please see our
Privacy
Policy.
END
RAGQKQBDBBKDQPD
Ekf Diagnostics (LSE:EKF)
Gráfica de Acción Histórica
De Oct 2024 a Nov 2024
Ekf Diagnostics (LSE:EKF)
Gráfica de Acción Histórica
De Nov 2023 a Nov 2024
